216 related articles for article (PubMed ID: 28248968)
1. Genomic variants reveal differential evolutionary constraints on human transglutaminases and point towards unrecognized significance of transglutaminase 2.
Thangaraju K; Király R; Demény MA; András Mótyán J; Fuxreiter M; Fésüs L
PLoS One; 2017; 12(3):e0172189. PubMed ID: 28248968
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism of transglutaminase 2: unusually low frequency of genomic variants with deficient functions.
Király R; Barta E; Fésüs L
Amino Acids; 2013 Jan; 44(1):215-25. PubMed ID: 22160262
[TBL] [Abstract][Full Text] [Related]
3. Computational analyses of the effect of novel amino acid clusters of human transglutaminase 2 on its structure and function.
Thangaraju K; Király R; Mótyán JA; Ambrus VA; Fuxreiter M; Fésüs L
Amino Acids; 2017 Mar; 49(3):605-614. PubMed ID: 27627884
[TBL] [Abstract][Full Text] [Related]
4. Functional significance of five noncanonical Ca2+-binding sites of human transglutaminase 2 characterized by site-directed mutagenesis.
Király R; Csosz E; Kurtán T; Antus S; Szigeti K; Simon-Vecsei Z; Korponay-Szabó IR; Keresztessy Z; Fésüs L
FEBS J; 2009 Dec; 276(23):7083-96. PubMed ID: 19878304
[TBL] [Abstract][Full Text] [Related]
5. TGM2 and implications for human disease: role of alternative splicing.
Lai TS; Greenberg CS
Front Biosci (Landmark Ed); 2013 Jan; 18(2):504-19. PubMed ID: 23276939
[TBL] [Abstract][Full Text] [Related]
6. Structure and organization of the human transglutaminase 3 gene: evolutionary relationship to the transglutaminase family.
Kim IG; Lee SC; Lee JH; Yang JM; Chung SI; Steinert PM
J Invest Dermatol; 1994 Aug; 103(2):137-42. PubMed ID: 7913719
[TBL] [Abstract][Full Text] [Related]
7. Transglutaminases are oncogenic biomarkers in human cancers and therapeutic targeting of TGM2 blocks chemoresistance and macrophage infiltration in pancreatic cancer.
Zhang S; Yao HF; Li H; Su T; Jiang SH; Wang H; Zhang ZG; Dong FY; Yang Q; Yang XM
Cell Oncol (Dordr); 2023 Oct; 46(5):1473-1492. PubMed ID: 37246171
[TBL] [Abstract][Full Text] [Related]
8. Structure of natural variant transglutaminase 2 reveals molecular basis of gaining stability and higher activity.
Ha HJ; Kwon S; Jeong EM; Kim CM; Lee KB; Kim IG; Park HH
PLoS One; 2018; 13(10):e0204707. PubMed ID: 30321187
[TBL] [Abstract][Full Text] [Related]
9. Organization and chromosomal mapping of mouse Gh/tissue transglutaminase gene (Tgm2).
Nanda N; Iismaa SE; Copeland NG; Gilbert DJ; Jenkins N; Graham RM; Sutrave P
Arch Biochem Biophys; 1999 Jun; 366(1):151-6. PubMed ID: 10334875
[TBL] [Abstract][Full Text] [Related]
10. On the early events of the calcium-induced activation of coagulation factor XIII-A
Fekete A; Komáromi I; Mucs D
J Biomol Struct Dyn; 2020 Jan; 38(1):152-167. PubMed ID: 30707083
[TBL] [Abstract][Full Text] [Related]
11. Screening for the preferred substrate sequence of transglutaminase using a phage-displayed peptide library: identification of peptide substrates for TGASE 2 and Factor XIIIA.
Sugimura Y; Hosono M; Wada F; Yoshimura T; Maki M; Hitomi K
J Biol Chem; 2006 Jun; 281(26):17699-706. PubMed ID: 16636049
[TBL] [Abstract][Full Text] [Related]
12. GTP-binding-defective forms of tissue transglutaminase trigger cell death.
Datta S; Antonyak MA; Cerione RA
Biochemistry; 2007 Dec; 46(51):14819-29. PubMed ID: 18052077
[TBL] [Abstract][Full Text] [Related]
13. Lack of genetic association of the TGM2 gene with schizophrenia in a Chinese population.
Wang J; Liu Y; Wang Z; Du W; Hui L; Zhao X; Zhao X; Zhang X; Wei J
Psychiatr Genet; 2015 Dec; 25(6):259-62. PubMed ID: 26307914
[TBL] [Abstract][Full Text] [Related]
14. Missense mutations in the TGM2 gene encoding transglutaminase 2 are found in patients with early-onset type 2 diabetes. Mutation in brief no. 982. Online.
Porzio O; Massa O; Cunsolo V; Colombo C; Malaponti M; Bertuzzi F; Hansen T; Johansen A; Pedersen O; Meschi F; Terrinoni A; Melino G; Federici M; Decarlo N; Menicagli M; Campani D; Marchetti P; Ferdaoussi M; Froguel P; Federici G; Vaxillaire M; Barbetti F
Hum Mutat; 2007 Nov; 28(11):1150. PubMed ID: 17939176
[TBL] [Abstract][Full Text] [Related]
15. Chronic liver injury drives non-traditional intrahepatic fibrin(ogen) crosslinking via tissue transglutaminase.
Poole LG; Pant A; Baker KS; Kopec AK; Cline-Fedewa HM; Iismaa SE; Flick MJ; Luyendyk JP
J Thromb Haemost; 2019 Jan; 17(1):113-125. PubMed ID: 30415489
[TBL] [Abstract][Full Text] [Related]
16. Site-directed mutation in conserved anionic regions of guinea pig liver transglutaminase.
Ikura K; Yu C; Nagao M; Sasaki R; Furuyoshi S; Kawabata N
Arch Biochem Biophys; 1995 Apr; 318(2):307-13. PubMed ID: 7733658
[TBL] [Abstract][Full Text] [Related]
17. Transglutaminase 2 is associated with adverse colorectal cancer survival and represents a therapeutic target.
Malkomes P; Lunger I; Oppermann E; Lorenz J; Faqar-Uz-Zaman SF; Han J; Bothur S; Ziegler P; Bankov K; Wild P; Bechstein WO; Rieger MA
Cancer Gene Ther; 2023 Oct; 30(10):1346-1354. PubMed ID: 37443286
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of transglutaminase 2 reduces efferocytosis in human macrophages: Role of CD14 and SR-AI receptors.
Eligini S; Fiorelli S; Tremoli E; Colli S
Nutr Metab Cardiovasc Dis; 2016 Oct; 26(10):922-30. PubMed ID: 27378395
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of naturally occurring transglutaminase 2 mutants implicated in early-onset type 2 diabetes.
Salter NW; Ande SR; Nguyen HK; Nyomba BL; Mishra S
J Mol Endocrinol; 2012 Jun; 48(3):203-16. PubMed ID: 22394545
[TBL] [Abstract][Full Text] [Related]
20. Isopeptidase activity of human transglutaminase 2: disconnection from transamidation and characterization by kinetic parameters.
Király R; Thangaraju K; Nagy Z; Collighan R; Nemes Z; Griffin M; Fésüs L
Amino Acids; 2016 Jan; 48(1):31-40. PubMed ID: 26250429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
